Secretoneurin assays

CardiNor provides access to secretoneurin testing through validated assay solutions, ongoing platform development, and collaborative biomarker analysis service.

CE-IVD secretoneurin ELISA

CardiNor has developed a CE‑IVD marked ELISA assay for the quantitative measurement of secretoneurin in blood samples.

Designed for use in both clinical laboratories and research settings, the assay provides a robust, standardised, and validated method for secretoneurin measurement.

Under development

Automated high-throughput solution

To support scalable and automated testing, CardiNor is currently adapting the secretoneurin assay to a high-throughput automated CLIA platform. This work is part of an ongoing technology transfer programme, with RUO testing becoming available in our service laboratory in the near term.

Contact us

For quotations or further information regarding assay access, biomarker analysis services, or research collaborations

Service laboratory and
biomarker analysis

Service laboratory and biomarker analysis

CardiNor shares a dedicated service laboratory with Pre Diagnostics, providing direct access to biomarker analysis within a well-established, quality-controlled environment. The laboratory is equipped with multiple immunoassay platforms, enabling the use of a broad range of commercially available assay kits depending on project requirements. While the technical infrastructure support broad assay flexibility, our primary focus is within cardiovascular and neurodegenerative diseases, where we have extensive scientific experience.

© 2026

Visiting address

c/o Horisont, Lørenveien 73A, 0585 Oslo

Part of

© 2026

Visiting address

c/o Horisont, Lørenveien 73A, 0585 Oslo

Part of

Visiting address

c/o Horisont, Lørenveien 73A, 0585 Oslo

Part of

Visiting address

c/o Horisont, Lørenveien 73A, 0585 Oslo

Part of